封面
市场调查报告书
商品编码
1935162

可程式输液帮浦和导管市场:按产品类型、按模式、按应用、按通道类型、按最终用户、按地区划分

Programmable Infusion Pumps and Catheters Market, By Product Type, By Modality, By Application, By Channel Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2026 年,可程式输液帮浦和导管市场价值将达到 139.05 亿美元,预计到 2033 年将达到 206.5 亿美元,2026 年至 2033 年的复合年增长率为 5.8%。

报告内容 报告详情
基准年: 2025 2026年市场规模: 139.05亿美元
历史数据时期: 2020年至2024年 预测期: 2026年至2033年
预测期(2026-2033年)复合年增长率: 5.80% 2033 年的预测值: 206.5亿美元

输液帮浦根据其工作原理进行分类。例如,在注射式帮浦中,液体储存在註射器储液器中,液体的输送由可移动的活塞控制。而弹性体帮浦则将液体储存在可拉伸的气囊储液器中,流速由气囊弹性壁的压力控制。这种由应用特性驱动的产品多样性预计将在预测期内对全球可编程输液帮浦和导管市场的成长产生积极影响。

市场动态

可程式设计输液帮浦相对于不可程式设计输液帮浦的优势预计将在预测期内推动全球可程式输液帮浦和导管市场的成长。例如,在静脉输液中使用不可程式设计输液帮浦会带来剂量控制不准和漏输等问题。例如,根据美国国家生物技术资讯中心 (NCBI) 的数据,2015 年 3 月至 4 月在衣索比亚进行的一项关于静脉给药错误 (MAE) 的研究报告显示,在 134 例病例中,MAE 的发生率为 46%,其中漏输是最常见的错误。然而,可程式输液帮浦的高成本预计将在一定程度上阻碍全球市场的成长。

本次调查的主要特点

  • 本报告对全球可程式输液帮浦和导管市场进行了详细分析,以 2025 年为基准年,给出了预测期(2026-2033 年)的市场规模和复合年增长率(%)。
  • 它还重点介绍了各个细分市场的潜在商机,并为该市场提出了一个有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、区域前景以及主要企业采取的竞争策略的重要见解。
  • 本报告根据以下参数对全球可程式输液帮浦和导管市场的主要企业进行了分析:公司概况、财务绩效、产品系列、地理分布、分销策略、关键发展和策略。
  • 本报告的研究结果将使负责人和经营团队能够透过技术升级、市场扩张和行销策略,就未来的产品发布做出明智的决策。
  • 这份全球可程式输液帮浦和导管市场报告的目标受众是该行业的各种相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种策略矩阵轻鬆做出决策,这些矩阵用于分析全球可编程输液帮浦和导管市场。

目录

第一章 研究目标与假设

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、监理及趋势分析

  • 市场动态
    • 司机
    • 抑制因素
    • 市场机会
    • 影响分析
  • 技术演进
  • PEST分析
  • 管道分析
  • 波特分析

4. 2026-2033年全球可程式输液帮浦和导管市场(依产品类型划分)

  • 容积式泵
  • 注射式帮浦
  • 肠内泵
  • 胰岛素帮浦
  • 植入式帮浦
  • 患者自控镇痛泵
  • 水泵配件

5. 2026-2033年全球可程式输液帮浦及导管市场(依输液划分)

  • 携带式的
  • 固定式

6. 2026-2033年全球可程式输液帮浦和导管市场(依应用领域划分)

  • 肿瘤学
  • 小儿科/新生儿科
  • 疼痛管理
  • 消化系统
  • 血液学
  • 糖尿病

7. 2026-2033年全球可程式输液帮浦和导管市场(依通道类型划分)

  • 单通道
  • 多通路娱乐

8. 2026-2033年全球可程式输液帮浦和导管市场(依最终用户划分)

  • 医院
  • 门诊部
  • 居家医疗
  • 诊所
  • 其他的

9. 2026-2033年全球可程式输液帮浦和导管市场(按地区划分)

  • 北美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • GCC
  • 以色列
  • 其他中东国家
  • 非洲
  • 中非
  • 南非
  • 北非

第十章 竞争格局

  • 公司简介
    • ICU Medical, Inc.
    • Smiths Group plc.
    • Baxter International Inc.
    • Fresenius Se &Co. KGaA
    • Johnson &Johnson
    • Medtronic plc.
    • Becton, Dickinson and Company
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Moog Inc.

第十一章各节

  • 参考
  • 调查方法
简介目录
Product Code: CMI2565

Programmable Infusion Pumps And Catheters Market is estimated to be valued at USD 13,905 Mn in 2026 and is expected to reach USD 20,650 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13,905 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.80% 2033 Value Projection: USD 20,650 Mn

Infusion pumps are classified depending on the mode of their operation. For instance, in a syringe pump, fluid is held in the syringe reservoir and the fluid delivery is controlled by a moveable piston, whereas in an elastomeric pump, a stretchable balloon reservoir contains fluid and its flow rate is controlled by the pressure from elastic walls of the balloon. Such product diversity, driven by the nature of its intended use, is expected to have a positive impact on global programmable infusion pumps and catheters market growth over the forecast period.

Market Dynamics

Advantages offered by programmable infusion pumps over non-programmable infusion pumps is expected to drive the global programmable infusion pumps and catheters market growth during the forecast period. For instance, the use of non-programmable infusion pumps for intravenous infusion is associated with problems such as uncontrolled dosing, possibility of missing dosage of medication, and others. For instance, according to National Center for Biotechnology Information (NCBI), in a study conducted on intravenous medication administration errors (MAEs) in Ethiopia, from March 2015 to April 2015, out of 134 cases the rate of MAE was reported to be 46%, with missed dosage being the most common error. However, high costs of programmable infusion pumps is expected to restrain global programmable infusion pumps market growth up to certain extent.

Key features of the study

  • This report provides in-depth analysis of global programmable infusion pumps and catheters market, and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and presents an attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, new product launches or approvals, regional outlooks, and competitive strategies adopted by leading players
  • It profiles leading players in the global programmable infusion pumps and catheters market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.
  • Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
  • The global programmable infusion pumps and catheters market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global programmable infusion pumps and catheters market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2026 - 2033)
    • Volumetric Pumps
    • Syringe Pumps
    • Enteral Pumps
    • Insulin Pumps
    • Implantable Pumps
    • Patient Controlled Analgesia Pumps
    • Pump Accessories
  • Modality Insights (Revenue, USD Mn, 2026 - 2033)
    • Portable
    • Stationary
  • Application Insights (Revenue, USD Mn, 2026 - 2033)
    • Oncology
    • Pediatrics/Neonatology
    • Pain
    • Gastroenterology
    • Hematology
    • Diabetes
  • Channel Type Insights (Revenue, USD Mn, 2026 - 2033)
    • Single Channel
    • Multi-channel
  • End User Insights (Revenue, USD Mn, 2026 - 2033)
    • Hospitals
    • Ambulatory Clinics
    • Homecare
    • Clinics
    • Others
  • Regional Insights (Revenue, USD Mn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • ICU Medical, Inc.
    • Smith's Group plc.
    • Baxter International Inc.
    • Fresenius Se & Co. KGaA
    • Johnson & Johnson
    • Medtronic plc.
    • Becton
    • Dickinson and Company
    • Terumo Corporation
    • Braun Melsungen AG
    • Moog Inc.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Modality
    • Market Snippet, By Application
    • Market Snippet, By Channel Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
  • Technological Evolution
  • PEST Analysis
  • Pipeline Analysis
  • Porter's Analysis

4. Global Programmable Infusion Pumps and Catheters Market, By Product Type, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Volumetric Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Syringe Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Enteral Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Insulin Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Implantable Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Patient Controlled Analgesia Pumps
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pump Accessories
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Programmable Infusion Pumps and Catheters Market, By Modality, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Portable
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Stationary
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Programmable Infusion Pumps and Catheters Market, By Application, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oncology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pediatrics/Neonatology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pain
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Gastroenterology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hematology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diabetes
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

7. Global Programmable Infusion Pumps and Catheters Market, By Channel Type, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Single Channel
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Multi-channel
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

8. Global Programmable Infusion Pumps and Catheters Market, By End User, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ambulatory Clinics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Homecare
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Clinics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

9. Global Programmable Infusion Pumps and Catheters Market, By Regions, 2026-2033 (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Country, 2026-2033 (USD Mn)
      • U.S.
      • Canada
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Modality, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Application, 2026-2033 (USD Mn)
    • Market Size and Forecast, By Channel Type, 2026-2033 (USD Mn)
    • Market Size and Forecast, By End User, 2026-2033 (USD Mn)
  • Central Africa
  • South Africa
  • North Africa

10. Competitive Landscape

  • Company Profiles
    • ICU Medical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Smiths Group plc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Baxter International Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fresenius Se & Co. KGaA
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic plc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Becton, Dickinson and Company
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Terumo Corporation
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • B. Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Moog Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact